Form D — Pheast Therapeutics, Inc.
0001231919-25-000321 · filed Oct 16, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Other Technology filings
Offering
- Industry
- Other Technology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $39,999,993
- Reported amount sold
- $24,588,083
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Pheast Therapeutics, Inc.
- CIK
- 1943737
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2020
- Address
- 200 CARDINAL WAY, STE 300
REDWOOD CITY, California 94063 - Phone
- 650-374-2223
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Roy Maute · Executive OfficerRedwood City, California Find on LinkedIn ↗
-
Amira Barkal · DirectorRedwood City, California Find on LinkedIn ↗
-
Steven Gillis · DirectorRedwood City, California Find on LinkedIn ↗
-
Jacob Vogelstein · DirectorRedwood City, California Find on LinkedIn ↗
-
Thomas Marty · Executive OfficerRedwood City, California Find on LinkedIn ↗
-
Raphael Rousseau · Executive OfficerRedwood City, California Find on LinkedIn ↗
-
Irving Weissman · DirectorRedwood City, California Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗